• On 14 July 2026, Arteris, Inc. reported that Arm is expanding its use of Arteris’ Cycuity Radix hardware security assurance technology across additional next‑generation CPU development programs to strengthen early-stage security verification and vulnerability mitigation.
• This deeper integration of Cycuity Radix into Arm’s design flow highlights Arteris’ growing role in addressing hardware security risks earlier in the silicon lifecycle.
• Next, we’ll examine how Arm’s broader integration of Cycuity Radix could influence Arteris’ investment narrative around AI-era semiconductor infrastructure.

This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.

Arteris Investment Narrative Recap

To own Arteris, I think you need to believe that its system IP and security tools become essential plumbing for increasingly complex AI era chips, turning today’s losses into operating leverage over time. The Arm expansion for Cycuity Radix supports the catalyst of deeper integration with tier one CPU suppliers, but does not, by itself, resolve near term risks around ongoing net losses, elevated R&D spend, and dependence on a concentrated set of large customers.

Among recent announcements, the IC-Link by imec collaboration is especially relevant, because it reinforces the same AI and chiplet infrastructure theme as the Arm news. While Arm highlights Arteris’ role in early stage CPU security verification, IC-Link shows its NoC IP being woven into reference designs for next generation AI and HPC chiplets, tying directly into the key catalyst of rising chiplet adoption and more complex custom silicon design starts.

Yet despite these promising partnerships, investors should still be aware that customer concentration and persistent losses could...

Arteris' narrative projects $151.4 million revenue and $18.3 million earnings by 2029.

Uncover how Arteris' forecasts yield a $37.75 fair value, a 16% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were already assuming about US$149,400,000 of 2029 revenue and no profits, so compared with the Arm security win and ongoing customer concentration risks, their view of Arteris’s future looks far more cautious than the consensus and may need revisiting as new information arrives.

Explore 4 other fair value estimates on Arteris - why the stock might be worth less than half the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Arteris research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free Arteris research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Arteris' overall financial health at a glance.

Want Some Alternatives?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Find 47 companies with promising cash flow potential yet trading below their fair value.
• The latest GPUs need a type of rare earth metal called Dysprosium and there are only 29 companies in the world exploring or producing it. Find the list for free.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.